Genentech regulatory update

GNE received U.S. Patents Nos. 5,618,788 and 5,618,789 covering methods to treat hemophiliacs with recombinant human

Read the full 165 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE